Literature DB >> 1979336

Lack of 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase/isomerase in fibroblasts from a child with urinary excretion of 3 beta-hydroxy-delta 5-bile acids. A new inborn error of metabolism.

M S Buchmann1, E A Kvittingen, H Nazer, T Gunasekaran, P T Clayton, J Sjövall, I Björkhem.   

Abstract

Cultured fibroblasts were shown to be capable of catalyzing the conversion of 7 alpha-hydroxy-cholesterol to 7 alpha-hydroxy-4-cholesten-3-one, an important reaction in bile acid synthesis. The apparent Km was approximately 7 mumol/liter and Vmax varied between 3 and 9 nmol/mg protein per h under the assay conditions used. The assay was used to investigate fibroblasts from a patient who presented with a familial giant cell hepatitis and who was found to excrete the monosulfates of 3 beta, 7 alpha-dihydroxy-5-cholenoic acid and 3 beta, 7 alpha, 12 alpha-trihydroxy-5-cholenoic acid in urine (Clayton, P. T., J. V. Leonard, A. M. Lawson, K. D. R. Setchell, S. Andersson, B. Egestad, and J. Sjövall. 1987. J. Clin. Invest. 79:1031-1038). In addition 7 alpha-hydroxy-cholesterol was found to accumulate in the circulation. Cultured fibroblasts from this boy were completely devoid of 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase/isomerase activity. Fibroblasts from his parents had reduced activity, compatible with a heterozygous genotype. The results provide strong evidence for the suggestion that this patient's liver disease was caused by a primary defect in the 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase/isomerase involved in bile acid biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1979336      PMCID: PMC329841          DOI: 10.1172/JCI114939

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  13 in total

1.  Reconstitution of C27-steroid 26-hydroxylase activity from bovine brain mitochondria.

Authors:  J I Pedersen; H Oftebro; I Björkhem
Journal:  Biochem Int       Date:  1989-03

2.  3 -Hydroxy- 5 -C 19 -and C 21 -steroid oxidoreductase activity in rat liver.

Authors:  I Björkhem; K Einarsson; J A Gustafsson
Journal:  Steroids       Date:  1972-04       Impact factor: 2.668

3.  On the mechanism of the enzymatic conversn of cholest-5-ene-3-beta, 7-alpha-diol into 7-alpha-hydroxycholest-4-en-3-one.

Authors:  I Björkhem
Journal:  Eur J Biochem       Date:  1969-04

Review 4.  Inborn errors of bile acid synthesis.

Authors:  K D Setchell; J M Street
Journal:  Semin Liver Dis       Date:  1987-05       Impact factor: 6.115

5.  3-Oxo-delta 4 bile acids in liver disease.

Authors:  P T Clayton; E Patel; A M Lawson; R A Carruthers; M S Tanner; B Strandvik; B Egestad; J Sjövall
Journal:  Lancet       Date:  1988-06-04       Impact factor: 79.321

6.  Delta 4-3-oxosteroid 5 beta-reductase deficiency described in identical twins with neonatal hepatitis. A new inborn error in bile acid synthesis.

Authors:  K D Setchell; F J Suchy; M B Welsh; L Zimmer-Nechemias; J Heubi; W F Balistreri
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

7.  Omega-hydroxylation of steriod side-chain in biosynthesis of bile acids.

Authors:  I Björkhem; J Gustafsson
Journal:  Eur J Biochem       Date:  1973-07-02

8.  Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme.

Authors:  S Andersson; D L Davis; H Dahlbäck; H Jörnvall; D W Russell
Journal:  J Biol Chem       Date:  1989-05-15       Impact factor: 5.157

9.  Role of peroxisomes in the biosynthesis of bile acids.

Authors:  I Björkhem; B F Kase; J I Pedersen
Journal:  Scand J Clin Lab Invest Suppl       Date:  1985

10.  Purification and properties of a 3 beta-hydroxy-delta 5-C27-steroid oxidoreductase from rabbit liver microsomes.

Authors:  K Wikvall
Journal:  J Biol Chem       Date:  1981-04-10       Impact factor: 5.157

View more
  14 in total

Review 1.  Review of progress in sterol oxidations: 1987-1995.

Authors:  L L Smith
Journal:  Lipids       Date:  1996-05       Impact factor: 1.880

2.  3 beta-hydroxy-delta 5-C27-steroid dehydrogenase deficiency; effect of chenodeoxycholic acid therapy on liver histology.

Authors:  S P Horslen; A M Lawson; M Malone; P T Clayton
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

3.  No linkage to the 3 beta-HSD gene cluster in a kindred affected with 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase deficiency and early onset hepatic failure.

Authors:  A Russell; H Nazer; A Shams; J Sjövall; R Sutcliffe
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

Review 4.  Genetics of familial intrahepatic cholestasis syndromes.

Authors:  S W C van Mil; R H J Houwen; L W J Klomp
Journal:  J Med Genet       Date:  2005-06       Impact factor: 6.318

Review 5.  Disorders of bile acid synthesis.

Authors:  Peter Theodore Clayton
Journal:  J Inherit Metab Dis       Date:  2011-01-13       Impact factor: 4.982

6.  Differential diagnosis in patients with suspected bile acid synthesis defects.

Authors:  Dorothea Haas; Hongying Gan-Schreier; Claus-Dieter Langhans; Tilman Rohrer; Guido Engelmann; Maura Heverin; David W Russell; Peter T Clayton; Georg F Hoffmann; Jürgen G Okun
Journal:  World J Gastroenterol       Date:  2012-03-14       Impact factor: 5.742

7.  Fifty years with bile acids and steroids in health and disease.

Authors:  Jan Sjövall
Journal:  Lipids       Date:  2004-08       Impact factor: 1.880

8.  The bile acid synthetic gene 3beta-hydroxy-Delta(5)-C(27)-steroid oxidoreductase is mutated in progressive intrahepatic cholestasis.

Authors:  M Schwarz; A C Wright; D L Davis; H Nazer; I Björkhem; D W Russell
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

Review 9.  Mechanisms of disease: Inborn errors of bile acid synthesis.

Authors:  Shikha S Sundaram; Kevin E Bove; Mark A Lovell; Ronald J Sokol
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-06-24

10.  Accumulation of 7 alpha-hydroxycholesterol in liver tissue of patients with cholesterol gallstones.

Authors:  A Honda; T Yoshida; N Tanaka; Y Matsuzaki; B He; J Shoda; T Osuga
Journal:  J Gastroenterol       Date:  1995-10       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.